VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON COMMERCIALISATION OF CORE PRODUCT YOCHANRA
02617 TransThera Sciences (Nanjing), Inc.TRANSTHERA-BHong Kong Stock Exchange (H-share)
4 posts
TransThera Sciences (Nanjing), Inc. (02617) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
TransThera Sciences (Nanjing), Inc. (02617) Stock Price HistoryNear a 52-week low
TransThera Sciences (Nanjing), Inc. closed at HK$8.54 on Oct 22, 2026, −20.6% over 1 month, −95.6% over 1 year.
If you had invested HK$10,000 1 month ago, it would be worth HK$7,944 today (−20.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.6%, while this stock moved −20.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Oct 22 (Thu) | HK$8.54 | −0.53 | −5.84% |
| Oct 21 (Wed) | HK$9.07 | −0.03 | −0.27% |
| Oct 20 (Tue) | HK$9.10 | −0.18 | −1.94% |
| Oct 16 (Fri) | HK$9.28 | +0.14 | +1.53% |
| Oct 15 (Thu) | HK$9.14 | −0.20 | −2.14% |
| Oct 14 (Wed) | HK$9.34 | −0.27 | −2.86% |
| Oct 13 (Tue) | HK$9.61 | −0.39 | −3.90% |
| Oct 12 (Mon) | HK$10.00 | −0.43 | −4.12% |
| Oct 9 (Fri) | HK$10.43 | +0.36 | +3.57% |
| Oct 8 (Thu) | HK$10.07 | +0.00 | +0.00% |
If you had invested HK$10,000 3 months ago, it would be worth HK$7,835 today (−21.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.9%, while this stock moved −21.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Oct 22 (Thu) | HK$8.54 | −0.53 | −5.84% |
| Oct 21 (Wed) | HK$9.07 | −0.03 | −0.27% |
| Oct 20 (Tue) | HK$9.10 | −0.18 | −1.94% |
| Oct 16 (Fri) | HK$9.28 | +0.14 | +1.53% |
| Oct 15 (Thu) | HK$9.14 | −0.20 | −2.14% |
| Oct 14 (Wed) | HK$9.34 | −0.27 | −2.86% |
| Oct 13 (Tue) | HK$9.61 | −0.39 | −3.90% |
| Oct 12 (Mon) | HK$10.00 | −0.43 | −4.12% |
| Oct 9 (Fri) | HK$10.43 | +0.36 | +3.57% |
| Oct 8 (Thu) | HK$10.07 | +0.00 | +0.00% |
If you had invested HK$10,000 6 months ago, it would be worth HK$1,415 today (−85.8%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −12.3%, while this stock moved −85.8%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Oct 2026 | HK$8.54 | −21.9% |
| Sep 2026 | HK$10.94 | +7.6% |
| Aug 2026 | HK$10.17 | +2.2% |
| Jul 2026 | HK$9.95 | −13.9% |
| Jun 2026 | HK$11.55 | −67.0% |
| May 2026 | HK$35.02 | −32.1% |
| Apr 2026 | HK$51.60 | −22.4% |
If you had invested HK$10,000 1 year ago, it would be worth HK$445 today (−95.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −11.0%, while this stock moved −95.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Oct 2026 | HK$8.54 | −21.9% |
| Sep 2026 | HK$10.94 | +7.6% |
| Aug 2026 | HK$10.17 | +2.2% |
| Jul 2026 | HK$9.95 | −13.9% |
| Jun 2026 | HK$11.55 | −67.0% |
| May 2026 | HK$35.02 | −32.1% |
| Apr 2026 | HK$51.60 | −22.4% |
| Mar 2026 | HK$66.50 | −3.5% |
| Feb 2026 | HK$68.90 | −16.6% |
| Jan 2026 | HK$82.65 | −28.1% |
| Dec 2025 | HK$115.00 | −42.7% |
| Nov 2025 | HK$200.60 | +9.1% |
| Oct 2025 | HK$183.80 | ― |
If you had invested HK$10,000 3 years ago, it would be worth HK$3,077 today (−69.2%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.6%, while this stock moved −69.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$8.54 | −92.6% |
| 2025 | HK$115.00 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2025). Please check the latest prices before trading.
Recent announcements (HKEXnews)
- 10/22 20:21 自社株買い/その他の株式異動 Next Day Disclosure Return
- 10/22 12:00 事業の状況 VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON COMMERCIALISATION OF CORE PRODUCT YOCHANRA
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON COMMERCIALISATION OF CORE PRODUCT YOCHANRA
INTERIM REPORT 2026
Delete
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH NOVEL HORMONAL THERAPY FOR PRETREATED AND PROGRESSED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CHINA
Delete
VOLUNTARY ANNOUNCEMENT INCLUSION OF YOCHANRA (TINENGOTINIB) IN THE CSCO GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF BILIARY TRACT CANCERS (2026)
Delete
Write on the TransThera Sciences (Nanjing), Inc. board
More Chinese stocks in English
- JD Logistics, Inc.02618
- X.J. Electrics (Hu Bei) Group Co., Ltd02619
- Shouhui Group Limited02621
- Hong Kong Gold Industry Group Limited02623
- JIANGSU HORIZON CHAIN SUPERMARKET COMPANY LIMITED02625
- Ab&B Bio-Tech CO., LTD. JS02627
- China Life Insurance Company Limited02628
- Mirxes Holding Company Limited02629
- Vigonvita Life Sciences Co., Ltd.02630
- SICC CO., LTD.02631
- JIANGSU NEW VISION AUTOMOTIVE ELECTRONICS CO., LTD.02632
- Jacobson Pharma Corporation Limited02633